Introduction
Renal tissue fibrosis is a major pathophysiological mechanism leading to end-stage renal failure in the course of diabetes, hypertension, renal ischemia and obstructive nephropathy [1, 2] . The renal pathology of chronic kidney disease is characterized by tubulo-interstitial fibrosis due to matrix deposition by myofibroblasts [3] . Myofibroblasts could originate from resident fibroblasts, bone-marrow-derived cells or from epithelial to mesynchymal transition (EMT), by which endothelial cells, glomerular podocytes and renal tubular cells transform into mesenchymal cells [3] [4] [5] . Myofibroblasts express mesenchymal cell products, such as α-smooth muscle actin (α-Sma) and collagen [6] .
Renal fibrosis is a hallmark of chronic kidney disease, regardless of its initial cause [1, 2, 7] . The process of renal fibrosis involves various signaling pathways, most notably the transforming growth factor TGFß pathway [1, 2, 6] . TGFß is involved in renal fibrosis following obstructive injury, diabetic nephropathy and other renal diseases [2] . TGFß strongly stimulates the expression of serum-and glucocorticoid-inducible kinase SGK1, a kinase implicated in fibrosing disease [8] . As a matter of fact, SGK1 is required for full stimulation of renal tissue fibrosis following unilateral ureteral obstruction [6] . SGK1-dependent signaling includes phosphorylation and thus inhibition of the glycogen synthase kinase GSK-3 [9] [10] [11] , which has in turn been implicated in the development of organ hypertrophy, fibrosis and EMT [6, [11] [12] [13] [14] [15] [16] [17] . GSK-3β is further phosphorylated by PKB, both of which are phosphorylated after unilateral ureteral obstruction [6, 18, 19] . In the unilateral ureteral obstruction (UUO) model, GSK-3 beta phosphorylation peaked 3 days after the onset of obstructive injury [6] . GSK-3β phosphorylation is an important early mechanism in the EMT of collecting duct cells [20] .
Wnt/ ß-catenin activation is a key event in renal fibrosis following UUO, and inhibition of this pathway reduces myofibroblast activation and renal fibrosis [14, 21] . GSK-3 in its active state initiates the degradation of ß-catenin, thereby inhibiting its activity [22, 23] . Both PKB/SGK and Wnt signaling cascades modify GSK-3, yet via distinct mechanisms and with distinct downstream effects [24, 25] . A crosstalk of PKB with ß-catenin signaling via GSK-3 has been suggested, but is still elusive [18, 26] . PKB/SGK-dependent phosphorylation of GSK-3 can be disrupted by replacement of the serine within the PKB/SGK phosphorylation sites by alanine (GSK-3α
) [18] . Gene-targeted mice carrying these mutations (gsk-3 KI ) should thus be resistant to signaling requiring PKB/SGK-dependent phosphorylation of GSK-3α/β [18, 27] .
In order to explore whether PKB/SGK-dependent phosphorylation of GSK-3α/β participates in the initiation of renal tissue fibrosis following obstructive nephropathy, the effects of shortterm unilateral ureteral obstruction [28, 29] were compared in gsk-3 KI mice and corresponding wild-type mice (gsk-3 WT ).
Materials and Methods

Animals
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities. Experiments have been performed in gene-targeted mice carrying a mutant GSK-3α/β, in which the codon encoding Ser9 of the GSK-3ß gene was changed to encode nonphosphorylatable alanine (GSK-3ß 9A/9A ), and simultaneously the codon encoding Ser21 of GSK-3α was changed to encode the nonphosphorylatable GSK-3α 21A/21A thus yielding the GSK-3α/β 21A/21A/9A/9A double knockin mouse (gsk-3
KI
) as described previously [18, 27] . The mice were compared to corresponding wild-type mice (gsk-3 WT ).
Unilateral ureteral obstruction
Renal fibrosis was induced by unilateral ureteral obstruction (UUO) [28, 29] . Following surgical incision of the skin and peritoneum, the left ureter was exposed and ligated twice with a non-resorbable 7-0 filament. Following ligation the surgical wound was closed by sutures. Mice were treated with metamizole Voelkl/Mia/Meissner/Ahmed/Feger/Elvira/Walker/Alessi/Alesutan/Lang: PKB/SGKResistant GSK-3 in UUO for analgesia (200 mg/kg BW) after the procedure and for the duration of the UUO experiment in drinking water. The mice were sacrificed 3 days after the ligation procedure and the obstructed as well as the nonligated kidney rapidly removed and kidney tissues snap frozen in liquid nitrogen.
Quantitative RT-PCR Total RNA was isolated from murine kidney tissues using Trifast Reagent (Peqlab) according to the manufacturer's instructions. Reverse transcription of 2 µg RNA was performed using oligo(dT) [12] [13] [14] [15] [16] [17] [18] The specificity of the PCR products was confirmed by analysis of the melting curves. All PCRs were performed in duplicate, and mRNA fold changes were calculated by the 2 -ΔΔCt method using Gapdh as internal reference. Results are shown normalized to the mRNA expression in the obstructed kidney tissues of gsk-3 WT mice.
Western blot analysis
Murine kidney tissues were lysed with ice-cold lysis buffer (Thermo Fisher Scientific) supplemented with complete protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). After centrifugation at 10000 rpm for 5 min, proteins were boiled in Roti-Load1 Buffer (Carl Roth GmbH) at 100ºC for 10 min. Proteins were separated on SDS-polyacrylamide gels and transferred to PVDF membranes. The membranes were incubated overnight at 4°C with the following primary antibodies: rabbit anti-α-smooth muscle actin, rabbit anti-collagen I (used at a 1:1000 dilution, Abcam), rabbit anti-phospho GSK-3α/β (Ser21/9), rabbit anti-GSK-3α, rabbit anti-GSK-3β, rabbit anti-β-catenin, rabbit anti-GAPDH antibody (used at a 1:1000 dilution, Cell Signaling) and then with secondary goat anti-rabbit HRP-conjugated antibody (diluted 1:1000, Cell Signaling) for 1 hour at room temperature. For loading controls, the membranes were stripped with stripping buffer (Carl Roth GmbH) at 56°C for 5 min. Antibody binding was detected with the ECL detection reagent (Thermo Fisher Scientific). Bands were quantified with Quantity One Software (Bio-Rad Laboratories) and results are shown as the ratio of phosphorylated to total protein and as the ratio of total protein to Gapdh.
Statistics
Data are provided as means ± SEM, n represents the number of independent experiments. All data were tested for significance between genotypes using unpaired Student t-test (normally distributed data) or Mann-Whitney test (non-normally distributed data) according to Shapiro-Wilk test. Only results with p < 0.05 were considered statistically significant.
Results
In a first series of experiments, a phospho-specific antibody for GSK-3α/β (Ser21/Ser9) was used to describe the difference in phosphorylation between gsk-3 knockin mice lacking functional PKB/SGK phosphorylation sites of GSK-3α/β (gsk-3
KI
) and their corresponding wild-type mice (gsk-3 WT ) in the non-obstructed contra-lateral kidney and in the obstructed kidney after a short term obstruction period (3 days). As illustrated in Fig. 1 , only weak GSK-Voelkl/Mia/Meissner/Ahmed/Feger/Elvira/Walker/Alessi/Alesutan/Lang: PKB/SGKResistant GSK-3 in UUO 3α and GSK-3β phosphorylation was observed in the non-obstructed kidney tissues of wildtype mice and no phosphorylation of GSK-3α and GSK-3β in renal tissues of gsk-3 KI mice. Within three days of unilateral ureteral obstruction, strong GSK-3α and GSK-3ß phosphorylation was observed in renal tissues from gsk-3 WT mice but not from gsk-3 KI mice (Fig. 1B,D) . In neither, the non-obstructed nor the obstructed kidney tissues, significant differences of total GSK-3α and GSK-3β protein abundance were observed between the genotypes (Fig. 1C,E) .
To quantify the relevance of PKB/SGK-dependent phosphorylation of GSK-3α/β on the fibrotic response after UUO, the expression of renal α-smooth muscle actin was determined (Fig. 2) . In the non-obstructed kidney tissues, mRNA levels and protein expression of α-smooth muscle actin were low and not significantly different between gsk-3 KI and gsk-3 WT mice. Following UUO treatment, the α-smooth muscle actin mRNA and protein levels were significantly less increased in kidney tissues from gsk-3 KI mice than in kidney tissues from gsk-3 WT mice. To further elucidate whether PKB/SGK-dependent phosphorylation of GSK-3α/β participates in the signaling of renal tissue fibrosis following UUO, the expression of type I collagen and type III collagen was determined (Fig. 3) . In non-obstructed kidney tissues, the protein abundance of collagen type I was not significantly different between gsk-3 KI mice and gsk-3 WT mice. Following UUO, the protein expression of collagen type I was significantly less increased in kidney tissues from gsk-3 KI mice than in kidney tissues from gsk-3 WT mice (Fig. 3A,B) . Furthermore, in non-obstructed control kidneys the renal mRNA expression of Col1a1 and Col3a1 was low and not significantly different between gsk-3 KI mice and gsk-3 WT mice. Following obstructive injury, the renal mRNA levels of both, Col1a1 and Col3a1 were again significantly less increased in gsk-3 KI mice than in gsk-3 WT mice (Fig. 3C,D) . Further experiments addressed the role of PKB/SGK-dependent phosphorylation of GSK-3α/β on ß-catenin protein abundance in non-obstructed control kidney tissues or UUO treated kidney tissues from gsk-3 KI mice and gsk-3 WT mice. As illustrated in Fig. 4 , ß-catenin protein expression was not significantly different between non-obstructed kidney tissues from gsk-3 KI and gsk-3 WT mice. Following UUO treatment, ß-catenin protein abundance was significantly less increased in renal tissues from gsk-3 KI mice as compared to renal tissues from gsk-3 WT mice. In order to explore the functional significance of differences in ß-catenin protein abundance in gsk-3 KI and gsk-3 WT mice following obstructive injury, the transcript levels of ß-catenin sensitive genes [14] : c-Myc, Dickkopf 1 (Dkk1), Twist and lymphoid enhancer-Voelkl/Mia/Meissner/Ahmed/Feger/Elvira/Walker/Alessi/Alesutan/Lang: PKB/SGKResistant GSK-3 in UUO binding factor 1 (Lef1) were determined. As shown in Fig. 5 , in the non-obstructed kidney tissues, the renal expression of the genes encoding: c-Myc, Dkk1 and Lef1 were not significantly different between gsk-3 KI and gsk-3 WT mice. The mRNA expression of Twist was significantly lower in the non-obstructed kidney tissues of gsk-3 KI mice as compared to non-obstructed kidney tissues from gsk-3 WT mice. Following UUO treatment, the renal transcript levels of the ß-catenin target genes: c-Myc, Dkk1, Twist and Lef1 were significantly less increased in renal tissues from gsk-3 KI mice than in renal tissues from gsk-3 WT mice.
Discussion
The present study sheds new light on the signaling of renal fibrosis following obstructive nephropathy. Disruption of PKB and SGK1-dependent phosphorylation of glycogen synthase Voelkl/Mia/Meissner/Ahmed/Feger/Elvira/Walker/Alessi/Alesutan/Lang: PKB/SGKResistant GSK-3 in UUO kinase GSK-3α/β significantly blunted the increase of collagen and α-smooth muscle actin expression following short term UUO. Furthermore, the renal ß-catenin protein abundance and transcript levels of the ß-catenin target genes: c-Myc, Dkk1, Twist and Lef1 following obstructive injury were significantly less increased in gsk-3 KI mice than in gsk-3 WT mice. Previous studies revealed the critical involvement of TGFß in the triggering of fibrosis of the kidney [2] . GSK-3 inactivation is an important mechanism in TGFß-induced senescence [30] . TGFß stimulates the expression of SGK1 [8] , which in turn significantly contributes to the stimulation of renal fibrosis following unilateral ureteral obstruction [6] . SGK1 is presumably at least in part effective by phosphorylating glycogen synthase kinase GSK-3, a known target of both SGK and AKT isoforms [9] [10] [11] . Both, AKT and SGK1 are upregulated following renal obstruction leading to increased phosphorylation of GSK-3β [6, 19] . Ample evidence points to a significant role of GSK-3 in the regulation of fibroblast differentiation and tissue fibrosis [6, 11, 12, 14, 15] . In cardiac tissue, for instance, the remodelling and fibrosis following beta-adrenergic challenge was blunted in gsk-3 KI mice [31] . A key signaling pathway promoting renal fibrosis is the Wnt/ß-catenin pathway [14, 21] . Wnt signals through GSK-3 to stabilize ß-catenin, a signaling process distinct from PKB/SGK1 signaling [22, 23, 32] . The ß-catenin protein abundance is similarly low in non-obstructed kidneys of gsk-3 KI and gsk-3 WT mice, but the increase of ß-catenin protein abundance in obstructed kidneys was blunted in gsk-3 KI mice as compared to gsk-3 WT mice. Following UUO, inhibition of PKB/SGK1-dependent phosphorylation of GSK-3 thus impacts on the Wnt/ß-catenin signaling pathway. Akt-sensitive ß-catenin activity has been observed earlier [32, 33] . The effect of PKB/SGK1 signaling on ß-catenin is, however, not necessarily direct, but could be secondary to other mechanisms [32] . For example, PKB/SGK1 -GSK-3 signaling regulates Snail, which fosters activation of ß-catenin and could thereby serve as the link between PI3K and Wnt/ß-catenin signalling [6, 16, 17, 20, 34] . In accordance with previous observations, PKB/SGK1-dependent GSK-3α/β phosphorylation is nonetheless an important event in renal fibrosis signaling [6, 20] . PKB/SGK is an important target for TGFβ in renal disease [8, 35] . At least in theory, PKB/ SGK-dependent phosphorylation of GSK-3α/β could similarly participate in the mechanisms triggering renal tissue fibrosis following other challenges, such as diabetes, hypertension and renal ischemia [1, 17, 20] . It is noteworthy that SGK1 is highly expressed in diabetic nephropathy [36] and kidney biopsies from proteinuric renal failure patients [37] . Moreover, SGK1 appears to be critically important for renal [38] and cardiac [15, 39, 40] fibrosis. Notably, mineralocorticoid-induced cardiac fibrosis was paralleled by enhanced GSK-3 phosphorylation, which was, however, not dependent on SGK1 and may have at least in part been due to phosphorylation by PKB isoforms [11] .
Conclusion
AKT and SGK1-dependent phosphorylation of glycogen synthase kinase GSK-3α/β participates in the signaling leading to renal tissue fibrosis and its disruption blunts the stimulation of fibrosis markers following unilateral ureteral obstruction.
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